Research news on our blog
New on our blog -- our Director of Research, Dr Kieran Breen, probes the reality behind the headlines.
A recent article claimed new drugs may shortly be available for treatment of atypical teratoid rhabdoid tumours (AT/RT), but is this really the case? Read more over on our blog.
You can find all of our recent research updates and news over on our blog -- other recent stories include insights into the American Society for Neuro-oncology annual meeting and looking to the future of licensing drugs for the treatment of brain tumours.